Apply to trial NCT07408336

A few quick questions so the study team can decide if you might be a fit.

RecruitingEarly Phase 1Biological intervention

Clinical Study of AFN50 Injection in the Autoimmune Diseases

This is an investigator-initiated trial designed to evaluate the safety, tolerability and primary efficacy of AFN50 injection for the treatment of autoimmune diseases.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Clinical Study of AFN50 Injection in the Autoimmune Diseases

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening